Replies to post #236722 on Biotech Values

[DewDiligence]

More color on BLUE’s separation into two companies:

https://www.barrons.com/articles/gene-therapy-firm-bluebird-bio-is-spinning-off-its-cancer-programs-51610370708

[DewDiligence]

BLUE spinoff on oncology business has 10/19/21 record date:

https://www.businesswire.com/news/home/20211018005572/en